pyridinolcarbamate has been researched along with Gastroduodenal Ulcer in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Excerpt | Relevance | Reference |
---|---|---|
"The use of HBO in the treatment of peptic ulcer raised the efficacy of the multimodality therapy and accelerated the epithelization of erosive and ulcerative defects." | 1.28 | [Evaluation of the therapeutic effect of hyperbaric oxygenation and anginin in peptic ulcer]. ( Chorbinskaia, SA; Elizavetina, GA; Izmalkova, NM; Vinnitskiĭ, LI; Vorob'eva, NT, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elizavetina, GA | 1 |
Vinnitskiĭ, LI | 1 |
Vorob'eva, NT | 1 |
Chorbinskaia, SA | 1 |
Izmalkova, NM | 1 |
1 other study available for pyridinolcarbamate and Gastroduodenal Ulcer
Article | Year |
---|---|
[Evaluation of the therapeutic effect of hyperbaric oxygenation and anginin in peptic ulcer].
Topics: Aged; Anti-Ulcer Agents; Carbamates; Combined Modality Therapy; Cyclic AMP; Cyclic GMP; Female; Gast | 1989 |